Cancer Research UK logo.
SearchDonate
  • Search

A trial of pembrolizumab for Hodgkin lymphoma (KEYNOTE667)

Overview

Cancer types:

Blood cancers, Children's cancers, Hodgkin lymphoma, Lymphoma

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at pembrolizumab after chemotherapy. It is open to children from 3 years old to young adults 25 years old who have classical Hodgkin lymphoma.

We use the term ‘you’ in the summary but if you are a parent we are referring to your child.

Recruitment start: 11 January 2021

Recruitment end: 21 September 2023

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Stephen Daw

Supported by

Merck Sharp & Dohme Ltd

Last reviewed: 01 Oct 2023

CRUK internal database number: 16883

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.